Dexmedetomidine improves excessive extracellular glutamate-induced synaptic depression (BRAINRES-D-21-00941)

Area of Science:

• Neuroscience
• Pharmacology
• Cellular Biology

Background:

• Excessive glutamate can cause excitotoxicity, leading to neuronal damage and secondary injury in the central nervous system.
• Understanding the mechanisms of glutamate-induced neuronal dysfunction is crucial for developing neuroprotective strategies.

Purpose of the Study:

• To investigate the neuroprotective effects of dexmedetomidine against glutamate-induced synaptic transmission depression in vitro.
• To elucidate the role of adrenergic receptors in mediating these protective effects.

Main Methods:

• In vitro electrophysiology was used to record synaptic transmission (population spikes and fEPSPs) in rat hippocampal slices.
• Glutamate was used to induce synaptic depression, and the effects of dexmedetomidine and other adrenergic agents were assessed.
• Statistical analysis was performed using ANOVA.

Main Results:

• Glutamate (10 mM) completely depressed synaptic transmission, with partial recovery upon washout.
• Pre-treatment and simultaneous administration of dexmedetomidine significantly improved synaptic transmission recovery.
• Beta-1 adrenergic stimulation (isoproterenol, dobutamine) exacerbated glutamate-induced depression, while NMDA receptor antagonism (AP5) showed protective effects.

Conclusions:

• Dexmedetomidine exhibits a protective effect against excessive glutamate-induced neuronal dysfunction.
• Alpha2-adrenergic receptor stimulation may be a therapeutic target for mitigating secondary central nervous system injury.
• Glutamate-induced depression is primarily mediated by NMDA receptors, with modulation by adrenergic receptor activity.